Biology subjects

Mancini, V.

Publications and source records attributed to Mancini, V..

4 recordsLinked to original sources

bioRxiv2026

Driving theta-gamma oscillations modulates extrasynaptic GABAergic tone: a tACS-TMS study

BACKGROUNDTheta-gamma phase-amplitude coupled ({theta}{gamma}-PAC) oscillations in primary motor cortex (M1) have been shown to support motor skill acquisition. Past research has shown that driving gamma activity at the theta peak (TGP), but not the theta trough (TGT) using transcranial alternating current stimulation (tACS) enhances motor learning (Akkad et al., 2021). However, the neurophysiological mechanisms underlying this phase-specific effect remain unclear. METHODSIn a double-blind, sham-controlled, cross-over study, twenty-two healthy participants received 20 minutes of 75Hz/6Hz TGP-tACS, TGT-tACS, or sham stimulation over M1. We used paired-pulse transcranial magnetic stimulation (TMS) to assess GABAergic and NMDAR-mediated activity before, during, and after tACS. Outcome measures included short-interval intracortical inhibition at 1ms (SICI1ms; extrasynaptic GABAergic tone) and 2.5ms (SICI2.5ms; synaptic GABAA activity), intracortical facilitation at 12ms (ICF12ms; NMDAR activity), and motor evoked potential (MEP) amplitude (corticospinal excitability). RESULTSTGP-tACS selectively decreased SICI1ms, a putative marker of extrasynaptic GABAergic tone (main effect of Stimulation: p=.021), with significant differences between TGP and TGT during late stimulation (p=.047). No significant effects were observed on corticospinal excitability, synaptic GABAergic activity (SICI2.5ms), or NMDAR signalling (ICF12ms). CONCLUSIONSDriving theta-gamma oscillations at the theta peak using tACS specifically modulates extrasynaptic GABAergic tone in M1 without affecting corticospinal excitability or synaptic inhibition. Given that reductions in GABAergic signalling supports motor learning, these findings provide a neurophysiological mechanism for the phase-specific behavioural effects of {theta}{gamma}-PAC tACS and suggest a potential therapeutic approach for facilitating motor recovery after stroke. HighlightsO_LITheta-gamma peak tACS selectively reduces extrasynaptic GABA in human motor cortex C_LIO_LIOnly gamma at the peak, not trough, of theta stimulation modulates GABA C_LIO_LINo effects on corticospinal excitability, synaptic GABA, or NMDAR signalling C_LIO_LItACS-TMS reveals mechanism for phase-dependent motor learning effects C_LI

neuroscience↗

bioRxiv2022

Neural integration and segregation revealed by a joint time-vertex connectome spectral analysis

Brain oscillations are produced by the coordinated activity of large groups of neurons and different rhythms are thought to reflect different modes of information processing. These modes, in turn, are known to occur at different spatial scales. Nevertheless, how these rhythms support different modes of information processing at the brain scale is not yet fully understood. Here we present "Joint Time-Vertex Connectome Spectral Analysis", a framework for characterizing the spectral content of brain activity both in time (temporal frequencies) and in space (spatial connectome harmonics). This method allows us to estimate the contribution of integration (global communication) and segregation (functional specialization) mechanisms at different temporal frequency bands in source-reconstructed M/EEG signals, thus providing a better understanding of the complex interplay between different information processing modes. We validated our method on two different datasets, an auditory steady-state response (ASSR) and a visual grating task. Our results suggest that different information processing mechanisms are carried out at different frequency channels: while integration seems to be a specific mechanism occurring at low temporal frequencies (alpha and theta), segregation is only observed at higher temporal frequencies (high and low gamma). Crucially, the estimated contribution of the integration and segregation mechanisms predicts performance in a behavioral task, demonstrating the neurophysiological relevance of this new framework.

neuroscience↗

bioRxiv2020

A new microfluidic concept for successful in vitro culture of mouse embryos

Innovative techniques for gene editing have enabled accurate animal models of human diseases to be established. In order for these methods to be successfully adopted in the scientific community, the optimization of procedures used for breeding genetically altered mice is required. Among these, the in vitro fertilization (IVF) procedure is still suboptimal and the culture methods do not guarantee the development of competent embryos. Critical aspects in traditional in vitro embryo culture protocols include the use of mineral oil and the stress induced by repetitive handling of the embryos. A new microfluidic system was designed to allow for efficient in vitro culture of mouse embryos. Harmful fluidic stress and plastic toxicity were excluded by completing the industry gold standard Mouse Embryo Assay. The potential competence of the embryos developed in the device was quantified in terms of blastocyst rate, outgrowth assay, energy substrate metabolism and expression of genes related to implantation potential. Mass spectrometry analyses identified plastic-related compounds released in medium, and confirmed leaching of low molecular weight species into the culture medium that might be associated to un-crosslinked PDMS. Finally, these data show the potential for the system to study preimplantation embryo development and to improve human IVF techniques.

bioengineering↗

bioRxiv2019

Polylactic acid, a sustainable, biocompatible, transparent substrate material for Organ-On-Chip and Microfluidic applications

Organ-on-chips are miniaturised devices aiming at replacing animal models for drug discovery, toxicology and studies of complex biological phenomena. The field of Organ-On-Chip has grown exponentially, and has led to the formation of companies providing commercial Organ-On-Chip devices. Yet, it may be surprising to learn that the majority of these commercial devices are made from Polydimethylsiloxane (PDMS), a silicone elastomer that is widely used in microfluidic prototyping, but which has been proven difficult to use in industrial settings and poses a number of challenges to experimentalists, including leaching of uncured oligomers and uncontrolled adsorption of small compounds. To alleviate these problems, we propose a new substrate for organ-on-chip devices: Polylactic Acid (PLA). PLA is a material derived from renewable resources, and compatible with high volume production technologies, such as microinjection moulding. PLA can be formed into sheets and prototyped into desired devices in the research lab. In this article we uncover the suitability of Polylactic acid as a substrate material for Microfluidic cell culture and Organ-on-a-chip applications. Surface properties, biocompatibility, small molecule adsorption and optical properties of PLA are investigated and compared with PDMS and other reference polymers.\n\nSignificanceOrgan-On-Chip (OOC) technology is a powerful and emerging tool that allows the culture of cells constituting an organ and enables scientists, researchers and clinicians to conduct more physiologically relevant experiments without using expensive animal models. Since the emergence of the first OOC devices 10 years ago, the translation from research to market has happened relatively fast. To date, at least 28 companies are proposing body and tissue on-a chip devices. The material of choice in most commercial organ-on-chip platforms is an elastomer, Polydymethyloxane (PDMS), commonly used in microfluidic R&D. PDMS is however subject to poor reproducibility, and absorbs small molecule compounds unless treated. In this study we show that PLA overcomes all the drawbacks related to PDMS: PLA can be prototyped in less than 45 minutes from design to test, is transparent, not autofluorescent, and biocompatible. PLA-based microfluidic platforms have the potential to transform the OOC industry as well as to provide a sustainable alternative for future Lab-On-Chip and point-of-care devices.

bioengineering↗